Viewing Study NCT04308759


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-26 @ 6:32 AM
Study NCT ID: NCT04308759
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-28
First Post: 2020-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Innovative Conversational Agent (Quitbot) for Smoking Cessation
Sponsor: Fred Hutchinson Cancer Center
Organization:

Study Overview

Official Title: Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.
Detailed Description: OUTLINE:

Participants are randomized to 1 of 2 groups. Both groups receive access to a 42-day quit smoking program.

GROUP I: Experimental program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.

GROUP II: Control program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2020-00136 REGISTRY CTRP (Clinical Trial Reporting Program) View
RG1006844 OTHER Fred Hutch/University of Washington Cancer Consortium View
R01CA247156 NIH None https://reporter.nih.gov/quic… View
10359 OTHER Fred Hutch/University of Washington Cancer Consortium View